168 related articles for article (PubMed ID: 24183966)
1. Pro-inflammatory cytokine-mediated ferroportin down-regulation contributes to the nigral iron accumulation in lipopolysaccharide-induced Parkinsonian models.
Zhang Z; Hou L; Song JL; Song N; Sun YJ; Lin X; Wang XL; Zhang FZ; Ge YL
Neuroscience; 2014 Jan; 257():20-30. PubMed ID: 24183966
[TBL] [Abstract][Full Text] [Related]
2. Intrapallidal lipopolysaccharide injection increases iron and ferritin levels in glia of the rat substantia nigra and induces locomotor deficits.
Zhang J; Stanton DM; Nguyen XV; Liu M; Zhang Z; Gash D; Bing G
Neuroscience; 2005; 135(3):829-38. PubMed ID: 16165292
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-10 protects against inflammation-mediated degeneration of dopaminergic neurons in substantia nigra.
Arimoto T; Choi DY; Lu X; Liu M; Nguyen XV; Zheng N; Stewart CA; Kim HC; Bing G
Neurobiol Aging; 2007 Jun; 28(6):894-906. PubMed ID: 21887889
[TBL] [Abstract][Full Text] [Related]
4. A comprehensive study on long-term injury to nigral dopaminergic neurons following intracerebroventricular injection of lipopolysaccharide in rats.
Zhou Y; Zhang Y; Li J; Lv F; Zhao Y; Duan D; Xu Q
J Neurochem; 2012 Dec; 123(5):771-80. PubMed ID: 22957701
[TBL] [Abstract][Full Text] [Related]
5. Pro-inflammatory cytokines modulate iron regulatory protein 1 expression and iron transportation through reactive oxygen/nitrogen species production in ventral mesencephalic neurons.
Wang J; Song N; Jiang H; Wang J; Xie J
Biochim Biophys Acta; 2013 May; 1832(5):618-25. PubMed ID: 23376588
[TBL] [Abstract][Full Text] [Related]
6. Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson's disease.
Zecca L; Wilms H; Geick S; Claasen JH; Brandenburg LO; Holzknecht C; Panizza ML; Zucca FA; Deuschl G; Sievers J; Lucius R
Acta Neuropathol; 2008 Jul; 116(1):47-55. PubMed ID: 18343932
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the lipopolysaccharide induced model of Parkinson's disease: Role of oxidative stress and neuroinflammation.
Sharma N; Nehru B
Neurochem Int; 2015 Aug; 87():92-105. PubMed ID: 26055970
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Src tyrosine kinase activity by squamosamide derivative FLZ attenuates neuroinflammation in both in vivo and in vitro Parkinson's disease models.
Tai W; Ye X; Bao X; Zhao B; Wang X; Zhang D
Neuropharmacology; 2013 Dec; 75():201-12. PubMed ID: 23916477
[TBL] [Abstract][Full Text] [Related]
9. Ferroportin 1 but not hephaestin contributes to iron accumulation in a cell model of Parkinson's disease.
Song N; Wang J; Jiang H; Xie J
Free Radic Biol Med; 2010 Jan; 48(2):332-41. PubMed ID: 19913091
[TBL] [Abstract][Full Text] [Related]
10. Ferroportin1 and hephaestin are involved in the nigral iron accumulation of 6-OHDA-lesioned rats.
Wang J; Jiang H; Xie JX
Eur J Neurosci; 2007 May; 25(9):2766-72. PubMed ID: 17561842
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective effect of nicotine on dopaminergic neurons by anti-inflammatory action.
Park HJ; Lee PH; Ahn YW; Choi YJ; Lee G; Lee DY; Chung ES; Jin BK
Eur J Neurosci; 2007 Jul; 26(1):79-89. PubMed ID: 17581257
[TBL] [Abstract][Full Text] [Related]
12. Chronic expression of low levels of tumor necrosis factor-alpha in the substantia nigra elicits progressive neurodegeneration, delayed motor symptoms and microglia/macrophage activation.
De Lella Ezcurra AL; Chertoff M; Ferrari C; Graciarena M; Pitossi F
Neurobiol Dis; 2010 Mar; 37(3):630-40. PubMed ID: 19969084
[TBL] [Abstract][Full Text] [Related]
13. Inflammation alters the expression of DMT1, FPN1 and hepcidin, and it causes iron accumulation in central nervous system cells.
Urrutia P; Aguirre P; Esparza A; Tapia V; Mena NP; Arredondo M; González-Billault C; Núñez MT
J Neurochem; 2013 Aug; 126(4):541-9. PubMed ID: 23506423
[TBL] [Abstract][Full Text] [Related]
14. Further characterisation of the LPS model of Parkinson's disease: a comparison of intra-nigral and intra-striatal lipopolysaccharide administration on motor function, microgliosis and nigrostriatal neurodegeneration in the rat.
Hoban DB; Connaughton E; Connaughton C; Hogan G; Thornton C; Mulcahy P; Moloney TC; Dowd E
Brain Behav Immun; 2013 Jan; 27(1):91-100. PubMed ID: 23044176
[TBL] [Abstract][Full Text] [Related]
15. Iron transport in Parkinson's disease.
Hirsch EC
Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S209-11. PubMed ID: 20082992
[TBL] [Abstract][Full Text] [Related]
16. New evidences for fractalkine/CX3CL1 involved in substantia nigral microglial activation and behavioral changes in a rat model of Parkinson's disease.
Shan S; Hong-Min T; Yi F; Jun-Peng G; Yue F; Yan-Hong T; Yun-Ke Y; Wen-Wei L; Xiang-Yu W; Jun M; Guo-Hua W; Ya-Ling H; Hua-Wei L; Ding-Fang C
Neurobiol Aging; 2011 Mar; 32(3):443-58. PubMed ID: 19368990
[TBL] [Abstract][Full Text] [Related]
17. Curcumin affords neuroprotection and inhibits α-synuclein aggregation in lipopolysaccharide-induced Parkinson's disease model.
Sharma N; Nehru B
Inflammopharmacology; 2018 Apr; 26(2):349-360. PubMed ID: 29027056
[TBL] [Abstract][Full Text] [Related]
18. The single intranigral injection of LPS as a new model for studying the selective effects of inflammatory reactions on dopaminergic system.
Herrera AJ; Castaño A; Venero JL; Cano J; Machado A
Neurobiol Dis; 2000 Aug; 7(4):429-47. PubMed ID: 10964613
[TBL] [Abstract][Full Text] [Related]
19. Role of p38 and inducible nitric oxide synthase in the in vivo dopaminergic cells' degeneration induced by inflammatory processes after lipopolysaccharide injection.
Ruano D; Revilla E; Gavilán MP; Vizuete ML; Pintado C; Vitorica J; Castaño A
Neuroscience; 2006 Jul; 140(4):1157-68. PubMed ID: 16713109
[TBL] [Abstract][Full Text] [Related]
20. Ulcerative colitis exacerbates lipopolysaccharide-induced damage to the nigral dopaminergic system: potential risk factor in Parkinson`s disease.
Villarán RF; Espinosa-Oliva AM; Sarmiento M; De Pablos RM; Argüelles S; Delgado-Cortés MJ; Sobrino V; Van Rooijen N; Venero JL; Herrera AJ; Cano J; Machado A
J Neurochem; 2010 Sep; 114(6):1687-700. PubMed ID: 20584104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
